Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Chyongchiou J. Lin is active.

Publication


Featured researches published by Chyongchiou J. Lin.


Vaccine | 2008

Alternative strategies for adult pneumococcal polysaccharide vaccination : A cost-effectiveness analysis

Kenneth J. Smith; Richard K. Zimmerman; Chyongchiou J. Lin; Mary Patricia Nowalk; Feng-Shou Ko; M. Catherine McEllistrem; Mark S. Roberts

Pneumococcal polysaccharide vaccination (PPV) to prevent invasive pneumococcal disease (IPD) is recommended at age 65 for most persons in the US. We used a Markov model to examine alternative PPV strategies, finding that vaccination at ages 50 and 65 prevented more IPD than present vaccination policies; four decennial vaccinations were most effective. The present vaccination policy costs


American Journal of Preventive Medicine | 2010

Improving influenza vaccination rates in the workplace: a randomized trial.

Mary Patricia Nowalk; Chyongchiou J. Lin; Seth L. Toback; Matthew D. Rousculp; Charles Eby; Mahlon Raymund; Richard K. Zimmerman

3341/QALY gained, vaccinations at 50/65 cost


Journal of Womens Health | 2010

Randomized Trial of an Alternate Human Papillomavirus Vaccine Administration Schedule in College-Aged Women

Richard K. Zimmerman; Mary Patricia Nowalk; Chyongchiou J. Lin; Dwight E. Fox; Feng-Shou Ko; Elizabeth Wettick; Gaye Cost; Linda Hand; Jennifer Hayes; Marian G. Michaels

23,120/QALY and four vaccinations (50/60/70/80) cost


Infection Control and Hospital Epidemiology | 2009

Factorial Design for Improving Influenza Vaccination Among Employees of a Large Health System

Richard K. Zimmerman; Mary Patricia Nowalk; Chyongchiou J. Lin; Mahlon Raymund; Dwight E. Fox; Jay D. Harper; Mark D. Tanis; Bayo Willis

54,451/QALY; results were sensitive to vaccine uptake assumptions, with current policy no longer favored at present vaccination rates. PPV at ages 50/65 may be clinically and, depending on cost-effectiveness criterion used, economically favored over present vaccination recommendations.


Infection Control and Hospital Epidemiology | 2008

Economic evaluation of standing order programs for pneumococcal vaccination of hospitalized elderly patients.

Donald B. Middleton; Chyongchiou J. Lin; Kenneth J. Smith; Richard K. Zimmerman; Mary Patricia Nowalk; Mark S. Roberts; Dwight E. Fox

BACKGROUND To minimize absenteeism resulting from influenza, employers frequently offer on-site influenza vaccination to employees. Yet the level of uptake of vaccine is low among working adults. This study was designed to increase workplace influenza vaccination rates by offering both a choice of intranasal (LAIV) and injectable (TIV) influenza vaccines to eligible employees, and an incentive for being vaccinated, and by increasing awareness of the vaccine clinic. DESIGN This study used a stratified randomized cluster trial. SETTING/PARTICIPANTS A total of 12,222 employees in 53 U.S. companies with previous influenza vaccine clinics were examined. INTERVENTIONS Control sites advertised and offered vaccine clinics as previously done. Choice sites offered LAIV or TIV and maintained their previous advertising level but promoted the choice of vaccines. Choice Plus sites increased advertising and promoted and offered a choice of vaccines and a nominal incentive. MAIN OUTCOME MEASURES These included vaccination rates among eligible employees. Hierarchic linear modeling (HLM) was used to determine factors associated with vaccination. RESULTS The overall vaccination rate increased from 39% in 2007-2008 to 46% in 2008-2009 (p<0.001). The difference in vaccination rates for LAIV was 6.5% for Choice versus Control and 9.9% for Choice Plus versus Control (both p<0.001). Rates of TIV increased by 15.9 percentage points in the Choice Plus arm versus Control for workers aged > or =50 years (p=0.024). Rates of TIV did not change in workers aged 18-49 years in either intervention arm or in workers aged > or =50 years in the Choice arm. In HLM analyses, factors significantly associated with increased vaccination were older age, female gender, previous company vaccination rate, and the Choice Plus intervention. CONCLUSIONS An incentive for vaccination, an intensified advertising campaign, and offering a choice of influenza vaccines improved vaccination rates in the workplace.


American Journal of Preventive Medicine | 2010

Research articleImproving Influenza Vaccination Rates in the Workplace: A Randomized Trial

Mary Patricia Nowalk; Chyongchiou J. Lin; Seth L. Toback; Matthew D. Rousculp; Charles Eby; Mahlon Raymund; Richard K. Zimmerman

BACKGROUND Human papillomavirus (HPV) vaccine is effective against HPV types 16 and 18, which cause 70% of cervical cancers. The three-dose vaccination schedule at 0, 2, and 6 months may be inconvenient for college-aged women. This study assessed noninferiority of the immune response to an alternate vaccination schedule at 0, 2, and 12 months. METHODS Two hundred nonpregnant women, aged 18-23 years, with <5 sexual partners were randomized into standard and alternate schedules. Blood samples were drawn before dose 1 and 2-6 weeks after dose 3 and analyzed with the competitive Luminex immunoassay. Seropositives at baseline were eliminated from analyses by HPV type. Log-transformed titers were used to calculate HPV type-specific geometric mean titers (GMTs) and 95% confidence intervals (CI) for each group. Noninferiority was tested against a one-sided null hypothesis that the post-dose 3 GMT ratio of the alternate to standard schedule was < or =0.5 for each HPV type. RESULTS One hundred eighty-eight women completed the study, with all 12 dropouts in the alternate schedule group (p < 0.001). Antibody responses in the alternate schedule were noninferior to the standard schedule for all vaccine types (p < 0.0001). Among the per-protocol population, GMTs (95% CI) for the alternate schedule were 4,440 (3,080-5,696), 5,688 (3,960-7,291), 12,443 (8,611-15,977), and 2,129 (1,183-3,063) for HPV types 6, 11, 16, and 18, respectively, vs. 2,153 (1,794-2,478), 1,966 (1,401-2,491), 6,218 (4,367-7,946), and 1,370 (1,167-1,553) for the standard schedule. Time between doses 2 and 3 significantly predicted final titer for all virus types (p < 0.005). CONCLUSIONS For all HPV vaccine types, the GMT ratios indicated noninferiority of the alternate vaccine administration schedule at 0, 2, and 12 months. The alternate schedule may be used to expand options for the timing of the third dose in the HPV vaccine schedule.


Annals of Family Medicine | 2006

Improving Influenza Vaccination Rates of High-Risk Inner-City Children Over 2 Intervention Years

Richard K. Zimmerman; Alejandro Hoberman; Mary Patricia Nowalk; Chyongchiou J. Lin; David P. Greenberg; Stuart T. Weinberg; Feng Shou Ko; Dwight E. Fox

OBJECTIVE As healthcare personnel (HCP) influenza vaccination becomes a quality indicator for healthcare facilities, effective interventions are needed. This study was designed to test a factorial design to improve HCP vaccination rates. DESIGN A before-after trial with education, publicity, and free and easily accessible influenza vaccines used a factorial design to determine the effect of mobile vaccination carts and incentives on vaccination rates of HCP, who were divided into groups on the basis of their level of patient contact (ie, business and/or administrative role, indirect patient contact, and direct patient contact). SETTING Eleven acute care facilities in a large health system. PARTICIPANTS More than 26,000 nonphysician employees. RESULTS Influenza vaccination rates increased significantly in most facilities and increased system-wide from 32.4% to 39.6% (P<.001). In the baseline year, business unit employee vaccination rates were significantly higher than among HCP with patient contact; rates did not differ significantly across groups in the intervention year. In logistic regression that accounted for demographic characteristics, intervention year, and other factors, the use of incentives and/or mobile carts that provided access to vaccine at the work unit significantly increased the likelihood of vaccination among HCP with direct and indirect patient contact, compared with control sites. CONCLUSIONS Interventions to improve vaccination rates are differentially effective among HCP with varying levels of patient contact. Mobile carts appear to remove access barriers, whereas incentives may motivate HCP to be vaccinated. Education and publicity may be sufficient for workers in business or administrative positions. Interventions tailored by worker type are likely to be most successful for improving HCP vaccination rates.


Infection Control and Hospital Epidemiology | 2005

Overcoming barriers to establishing an inpatient vaccination program for pneumococcus using standing orders.

Donald B. Middleton; Dwight E. Fox; Mary Patricia Nowalk; Susan J. Skledar; Denise R. Sokos; Richard K. Zimmerman; Kelly A. Ervin; Chyongchiou J. Lin

BACKGROUND Standing order programs (SOPs), which allow for vaccination without an individual physician order, are the most effective mechanism to achieve high vaccination rates. Among the suggested settings for the utilization of SOPs are hospital inpatient units, because they provide care for those most likely to benefit from vaccination. The cost-effectiveness of this approach for elderly hospitalized persons is unknown. The purpose of this study was to estimate the cost-effectiveness of SOPs for pneumococcal polysaccharide vaccine (PPV) vaccination for patients 65 years of age or older in 2 types of hospital. METHODS In 2004, a 1,094-bed tertiary care hospital implemented a pharmacy-based SOP for PPV, and a 225-bed community hospital implemented a nursing-based SOP for PPV. Newly admitted patients 65 years of age or older were screened for PPV eligibility and then offered PPV. Vaccination rates before and after initiation of SOPs in the United States, incidence rates of invasive pneumococcal disease in the United States, and US economic data were the bases of the cost-effectiveness analyses. One-way and multivariate sensitivity analyses were conducted. RESULTS PPV vaccination rates increased 30.5% in the tertiary care hospital and 15.3% in the community hospital. In the base-case cost-effectiveness analysis, using a societal perspective, we found that both pharmacy-based and nursing-based SOPs cost less than


Vaccine | 2010

Importance of vaccination habit and vaccine choice on influenza vaccination among healthy working adults

Chyongchiou J. Lin; Mary Patricia Nowalk; Seth L. Toback; Matthew D. Rousculp; Mahlon Raymund; Christopher S. Ambrose; Richard K. Zimmerman

10,000 per quality-adjusted life-year gained, with program costs (pharmacy-based SOPs cost


Journal of the American Geriatrics Society | 2017

Using the 4 Pillars Practice Transformation Program to Increase Pneumococcal Immunizations for Older Adults: A Cluster‐Randomized Trial

Richard K. Zimmerman; Anthony E. Brown; Valory N. Pavlik; Krissy K. Moehling; Jonathan M. Raviotta; Chyongchiou J. Lin; Song Zhang; Mary Hawk; Shakala Kyle; Suchita Patel; Faruque Ahmed; Mary Patricia Nowalk

4.16 per patient screened, and nursing-based SOPs cost

Collaboration


Dive into the Chyongchiou J. Lin's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dwight E. Fox

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar

Mahlon Raymund

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Diana H. Kearney

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bruce Block

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge